S-Adenosylhomocysteine hydrolase of mammalian hearts from different species is exclusively a cytosolic enzyme. The apparent Km for the guinea-pig enzyme was 2.9,uM (synthesis) and 0.39,UM (hydrolysis). Perfusion of isolated guinea-pig hearts for 120min with L-homocysteine thiolactone (0.23 mM) and adenosine (0.1 mM), in the presence of erythro-9-(2-hydroxynon-3-yl)adenine to inhibit adenosine deaminase, caused tissue contents of S-adenosylhomocysteine to increase from 3.5 to 3600nmol/g. When endogenous adenosine production was accelerated by perfusion of hearts with hypoxic medium (30% 02), L-homocysteine thiolactone (0.23 mM) increased S-adenosylhomocysteine 17-fold to 64.3 nmol/g within 15 min. In the presence of 4-nitrobenzylthioinosine (5,uM), an inhibitor of adenosine transport, S-adenosylhomocysteine further increased to 150nmol/g. L-Homocysteine thiolactone decreased the hypoxiainduced augmentation of adenosine, inosine and hypoxanthine in the tissue and the release of these purines into the coronary system by more than 50%. Our findings indicate that L-homocysteine can profoundly alter adenosine metabolism in the intact heart by conversion of adenosine into S-adenosylhomocysteine. Adenosine formed during hypoxia was most probably generated within the myocardial cell.
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Adenosine has received much attention in recent years because of its possible involvement in regulating heart, smooth-muscle, neural and immune function (Fox & Kelley, 1978; Baer & Drummond, 1979) . Specific adenosine receptors located in the membrane have been identified in various tissues (Olsson et al., 1976; Schrader et al., 1977a) , and are thought to modulate the activity of adenylate cyclase directly (Londos et al., 1978) .
In the heart, as well as in most other organs, formation and release of adenosine appear to be critically dependent on the equilibrium between supply and demand for oxygen (Berne et al., 1979) . Factors leading to tissue hypoxia by either diminished oxygen supply or enhanced oxygen demand are known to be potent stimuli for adenosine production.
The site of adenosine formation is generally assumed to be the plasma membrane, mainly because of the location of 5'-nucleotidase (Rubio et al., 1973) . Functional studies, however, suggest that adenosine may also be formed and accumulate * Present address: Department of Pharmacology, University of Vienna, Wahringer Strasse 13a, A-1090 Vienna, Austria. intracellularly (Schrader & Schuitz, 1979) . Another possible source for myocardial adenosine formation, besides dephosphorylation of 5'-AMP, is the pathway leading from S-adenosylmethionine via S-adenosylhomocysteine to adenosine. Adenosine may thus be formed as an obligatory product of S-adenosylmethionine-dependent methylation reactions. A key enzyme in this pathway directly leading to the formation of adenosine is S-adenosylhomocysteine hydrolase (EC 3.3.1.1), which was first described by de la Haba & Cantoni (1959) in rat liver and which was more recently purified to homogeneity (Richards et al., 1978) . The reaction catalysed by this enzyme is reversible, with equilibrium far in the direction of S-adenosylhomocysteine synthesis (de la Haba & Cantoni, 1959) .
Little attention has been paid in the past to the role of S-adenosylhomocysteine hydrolase in the metabolism of adenosine in whole tissue. In view of the regulatory function ascribed to myocardial adenosine [dilation of coronary vessels (Olsson, 1970; Schrader et al., 1977a; Berne et al., 1979) and attenuation of the action of fi-adrenergic stimulation (Schrader et al., 1977b; Dobson, 1978 1 mM-mercaptoethanol and 1 mM-MgCI2, strained through a double-layered nylon sieve and again homogenized for min (Potter/Elvehjem homogenizer, Teflon pestle). A crude membrane preparation was obtained by centrifugation of a sample of the homogenate at 1000g for 10 min, and washing the resulting pellet three times with the same buffer. For preparation of the cytosolic fraction, the homogenate was first centrifuged at 3000g for 10 min and the resulting supernatant was again centrifuged at 2200OOg for 60min. The cytosolic fraction was then dialysed for 4h against an excess of 10mM-Hepes buffer, pH7.4, containing 1mm-mercaptoethanol, 1mM-MgCl2 and 0.01% activated charcoal to adsorb all purine compounds.
The rate of hydrolysis of S-adenosylhomocysteine was determined by measuring the formation of uric acid by using a newly developed spectrophotometric assay. The reaction mixture (2 ml) contained 25 mM-Hepes, pH 7.4, 2 mM-MgCI2, 0.1 mM-NaH2PO4, 0.5-20#uM-S-adenosylhomocysteine, 8 units of adenosine deaminase, 2 units of purine nucleoside phosphorylase and 2 units of xanthine oxidase at 37°C. Reaction was started by addition of the cytosolic fraction containing Sadenosylhomocysteine hydrolase (160-380,ug of protein). Since S-adenosylhomocysteine hydrolase activity was adjusted to be the rate-limiting enzyme, changes in absorbance at the wavelength of uric acid (295nm, reference beam at 325nm) directly reflected the activity of the enzyme. Protein was determined as described by Bradford (1976) .
Synthesis of S-adenosylhomocysteine from adenosine and L-homocysteine was assayed in a 0.2 ml reaction mixture containing 25 mM-Hepes, pH 7.4, 2mM-MgCl2, 20pM-erythro-9 -(2 -hydroxynon-3-yl)adenine to inhibit adenosine deaminase and 0. 2-50,uM-[8-14C] adenosine (2 x 104c.p.m./assay tube). Activity of S-adenosylhomocysteine hydrolase was determined at either constant adenosine (50UM) or constant L-homocysteine (2 mM) concentrations while L-homocysteine or adenosine was varied respectively. L-Homocysteine was prepared from its thiolactone by alkaline hydrolysis (Hershfield & Kredich, 1978) . Reaction was started by addition of cytosolic protein (90,ug) . Incubation was for 10min at 370C, followed by heat-inactivation at 950C for 2min. A 200,l portion was spotted with carrier amounts of adenosine and S-adenosylhomocysteine on silica-gel UV254 thin-layer plates, which were developed for 3 h in butan-1-ol/ethyl acetate/methanol/25% (v/v) NH3 (7:4:3:3, by vol.). RF values for adenosine and S-adenosylhomocysteine were identified under u.v. light, and the spots were scraped off and counted for radioactivity (Schrader & Gerlach, 1977) ,
Animal experiments
Isolated hearts from guinea pigs, prepared as described by Schrader et al. (1978b) , were perfused via the aorta with a modified Krebs-Henseleit solution (Schrader & Gerlach, 1977) equilibrated with either 02/CO2 (19: 1) (normoxia) or 02/ C02/N2 (6:1:13) (hypoxia). Hearts were electrically paced at 270beats/min, and intraventricular pressure development and coronary perfusion pressure were continuously monitored in each heart. After an equilibration period of 20 min under normoxic conditions (perfusion pressure 60cmH2O), perfusion was changed to constant flow in order to assure constant 02 supply under all experimental conditions. Flow was initially adjusted to yield a perfusion pressure of 80cmH2O. When intraventricular pressure development and perfusion pressure had attained constant values, perfusion was continued for an additional 15min with normoxic or hypoxic medium, with or without L-homocysteine thiolactone and/or 4-nitrobenzylthioinosine.
Determination of S-adenosylhomocysteine, adenosine, inosine and hypoxanthine Hearts, still attached to the perfusion cannula, were frozen between two aluminium blocks precooled to the temperature of liquid N2 and freezedried. After removal of connective and atrial tissue, ventricular myocardium was extracted with 10ml of 0.5 M-HClO4 and the extract was carefully neutralized with KOH. The neutralized extract was then treated with activated charcoal as described by Schrader & Gerlach (1977) , and adenosine and S-adenosylhomocysteine were separated on silicagel UV254 thin-layer plates in the solvent system mentioned above. The u.v.-absorbing areas representing adenosine and S-adenosylhomocysteine were scraped off, eluted and quantified spectrophotometrically by successive enzymic degradation to uric acid (Schrader & Gerlach, 1977) . Degradation of S-adenosylhomocysteine to adenosine was accomplished by addition of 2 units of S-adenosylhomocysteine hydrolase (sp. activity 40umol/min per mg of protein), prepared from rat liver as described by de la Haba & Cantoni (1959) . With a double-beam dual-wavelength spectrophotometer (Perkin-Elmer model 356) as little as lOOpmol of adenosine and S-adenosylhomocysteine could be detected.
Recovery of S-adenosylhomocysteine and hydrolytic cleavage of S-adenosylhomocysteine to adenosine during the extraction procedure was determined in each experiment by addition of lOnCi of S-[8-14Cladenosylhomocysteine to the acid extract. Recovery of S-adenosylhomocysteine was 44.5 + 1.6% (+ S.E.M., n = 18). Hydrolysis of Sadenosylhomocysteine was 2.15 + 0.35% (± S.E.M., n = 11). Values given for S-adenosylhomocysteine and adenosine are corrected for individual recoveries and amount of adenosine formed from S-adenosylhomocysteine respectively. S-[8-'4C lAdenosylhomocysteine was prepared from F8-'4Cladenosine (sp. radioactivity 51 mCi/mmol), 2O,UM-erythro-9-(2-hydroxynon-3-yl)adenine, 1 mM-EDTA and 2 units of S-adenosylhomocysteine hydrolase. Incubation for 10min at 37°C was terminated by heat-inactivation at 950C for 2min. Purification of labelled S-adenosylhomocysteine was by t.l.c. on silica-gel plates as described above. For analysis of adenosine, inosine and hypoxanthine, released by the heart, coronary-effluent perfusate was collected in lOml of 0.6M-HCI04. The different purine compounds were determined as described previously (Schrader & Gerlach, 1977) .
Results

S-Adenosylhomocysteine in hearts ofdifferent mammalian species
In all species investigated, S-adenosylhomocysteine hydrolase was found to be present solely in the cytosolic fraction (22000Og supernatant) prepared from ventricular myocardium; no activity could be detected in a washed particulate membrane preparation. There were, however, considerable species differences (Table 1) . Although the highest activity values were found in hearts of guinea pigs, lowest values were determined for the dog heart, differing by a factor of about 20.
The apparent Km value for guinea-pig heart S-adenosylhomocysteine hydrolase was 2.9 pM when assayed in the hydrolytic direction (Table 2) . Similar values have been reported for other tissues (Richards et al., 1978; Hershfield & Kredich, 1978; Kajander et al., 1976) . When measured in the direction of S-adenosylhomocysteine synthesis, the apparent Km value for homocysteine was in the millimolar range, whereas the Km for adenosine was as low as 0.39 pM. Influence of L-homocysteine on adenosine metabolism during normoxic and hypoxic perfusion Perfusion of well-oxygenated (95% 02) isolated guinea-pig hearts for 15min with 0.23 mM-L-homo- Table 2 . Kinetic properties of S-adenosylhomocysteine hydrolase determined in the 220000g supernatant of guinea-pig ventricular myocardium
The assay of S-adenosylhomocysteine hydrolase activity was carried out as described in the Materials and methods section. Synthesis of S-adenosylhomocysteine was measured at constant adenosine (50UM) or constant L-homocysteine (2 mM) concentrations while L-homocysteine or adenosine was varied respectively. Apparently Vmax. (Table 3) . Under these conditions adenosine content did not significantly change.
Completely different results were obtained when endogenous adenosine production was accelerated by perfusion of the hearts with hypoxic medium (30% 02). Hypoxia alone caused adenosine to increase from 1.64 to 3.53 nmol/g, but S-adenosylhomocysteine content did not change. In the presence of L-homocysteine thiolactone, however, S-adenosylhomocysteine increased by a factor of 17, whereas adenosine decreased by about 50%. Similar changes were also observed in inosine and hypoxanthine, which decreased from 8.1 + 0.5 and 6.0+0.5nmol/g to 5.1 + 1.3 and 3.9+0.9nmol/g respectively (+ S.E.M.; P < 0.002; n = 5).
In an attempt to increase tissue adenosine content further, we used 4-nitrobenzylthioinosine, a potent inhibitor of nucleoside transport across cellular membranes (Paterson et al., 1977) . 4-Nitrobenzylthioinosine (5 pM) greatly potentiated the hypoxiainduced increase in tissue adenosine. In the presence of such elevated cellular adenosine contents, Lhomocysteine caused a further increase in myocardial S-adenosylhomocysteine, but adenosine again was decreased.
Analyses of coronary-effluent perfusates of isolated guinea-pig hearts showed that hypoxia (30%) also greatly augmented the release of adenosine and its degradation products, inosine and hypoxanthine (Table 4) . L-Homocysteine thiolactone (0.23 mM) drastically diminished this effect. The total decrease in the amount of purine compounds liberated under these conditions was 64 nmol/15min per g. This value compares well with the tissue content of S-adenosylhomocysteine accumulating over the same period of time (Table 3 ). There was no detectable release of S-adenosylhomocysteine from isolated hearts in experiments with L-homocysteine thiolactone.
Effect of L-homocvsteine and infused adenosine on S-adenosylhomocysteine contents When isolated guinea-pig hearts were perfused simultaneously with adenosine (0.1 mM) and L- (Fig. 1) . In the prese 9-(2-hydroxynon-3-yl)adenine, whic sine deaminase, the increase in ' cysteine was even greater. After fusion under these conditions, ' cysteine increased from 3.47nmol, this nucleoside in the tissue and its release into the vascular system. This action of L-homocysteine may provide a suitable experimental tool with which to evaluate in further studies the possible role of adenosine in the heart and other tissues (Fox & Kelley, 1978; Baer & Drummond, 1979) . S-Adenosylhomocysteine hydrolase was shown to bind adenosine tightly (Hershfield & Kredich, 1978) . From the kinetic parameters of a highly purified S-adenosylhomocysteine hydrolase [Vmax -o 0.5,umol/min per mg of protein; mol.wt. 237500 (Richards et al., 1978) ], the adenosine-binding properties of the enzyme (2mol of adenosine/mol of enzyme; M. Hershfield, personal communication) and the specific activity of the cardiac enzyme (38.1 nmol/min per g of ventricle in the guinea pig), it can be calculated that about 0.6 nmol of adenosine/g of ventricle is bound to S-adenosylhomocysteine hydrolase. Such a value would decrease the measured tissue content of adenosine in 90 120 the guinea-pig heart (1.64nmol/g) by about 37%. It is noteworthy that the dog heart, which exhibits a onocysteine in the very low S-adenosylhomocysteine hydrolase acc adenosine tivity, is also characterized by a low tissue content of constant flow adenosine [0.3 nmol/g (Olsson, 1970) ]. Thus the Krebs-Henseleit amount of S-adenosylhomocysteine hydrolase preine thiolactone sent in each tissue may be a major factor deteri). erythro-9-(2-mining the total tissue content of adenosine. ,as either absent S-Adenosylhomocysteine hydrolase proved to be ;ion medium. exclusively a cytosolic enzyme in the heart. It is therefore reasonable to assume that adenosine, the substrate for this enzyme, must have accumulated intracellularly in order to explain its conversion into S-adenosylhomocysteine. The possibility that ), tissue S-adenoadenosine was first released by the heart and then rably increased trapped by L-homocysteine after its reuptake apXnce of erythropears unlikely, since inhibition of adenosine trans-:h inhibits adenoport by 4-nitrobenzylthioinosine (Paterson et al., S-adenosylhomo-1977 ) not only greatly augmented tissue content of 120 min of peradenosine, but also potentiated the effect of L-S-adenosylhomohomocysteine on S-adenosylhomocysteine (Table   /g high as 3600nmol/g. Despite the greatly enlarged S-adenosylhomocysteine pool, contractile-force development of the isolated hearts was not significantly altered.
Discussion
The present paper demonstrates that perfusion of intact hearts with L-homocysteine greatly diminishes tissue content and release of vasoactive adenosine during hypoxia. This effect does not result from changes in oxygen supply to the heart, but is due to the conversion of adenosine into S-adenosylhomocysteine by action of S-adenosylhomocysteine hydrolase. L-Homocysteine therefore can uncouple production of adenosine from the accumulation of Vol. 196 No values have been reported so far for the normal tissue content and plasma concentration of L-homocysteine (Mudd & Levy, 1978) . Only in plasma of patients with homocysteinuria was Lhomocysteine measured to be in the millimolar range (Mudd & Levy, 1978) . On the basis of our results, and owing to the ubiquitous distribution of Sadenosylhomocysteine hydrolase (Eloranta, 1977) , homocysteinuria is likely also to be associated with severe alterations in the metabolism of adenosine.
S-Adenosylhomocysteine is known to inhibit numerous S-adenosylmethionine-dependent methylation reactions (Usdin et al., 1979) , and inhibition of membrane phospholipid methylation was reported to influence coupling of fJ-adrenergic receptors to adenylate cyclase (Strittmatter et al., 1 979b) as well as ion fluxes (Strittmatter et al., 1979a) . Although S-adenosylhomocysteine increased in the present study to extraordinary high values, which are in the range of myocardial ATP concentration f3940nmol/g (Schrader & Gerlach, 1977 )1 contractile-force development of the heart remained unchanged. Furthermore, preliminary observations indicate that under these conditions the contractile response of the isolated heart to fl-adrenergic stimulation does not change. Thus the significance of methylation reactions for the function of the heart remains to be elucidated.
